ESPR · Esperion Therapeutics, Inc.
Market Cap
$818.63M
Shares
257.43M
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
| 2026-06-30 | 17,401,689 | 20,719,122 | -3,317,433 | 1.74 |
| 2026-06-15 | 20,719,122 | 18,714,926 | +2,004,196 | 1.76 |
| 2026-05-29 | 18,714,926 | 20,207,976 | -1,493,050 | 2.68 |
| 2026-05-15 | 20,207,976 | 36,425,941 | -16,217,965 | 1.00 |
| 2026-04-30 | 36,425,941 | 31,830,830 | +4,595,111 | 5.18 |
| 2026-04-15 | 31,830,830 | 33,129,776 | -1,298,946 | 3.73 |
| 2026-03-31 | 33,129,776 | 33,731,852 | -602,076 | 6.98 |
| 2026-03-13 | 33,731,852 | 33,525,831 | +206,021 | 5.05 |
| 2026-02-27 | 33,525,831 | 33,567,190 | -41,359 | 13.60 |
| 2026-02-13 | 33,567,190 | 33,452,416 | +114,774 | 9.38 |
| 2026-01-30 | 33,452,416 | 37,439,023 | -3,986,607 | 6.52 |
| 2026-01-15 | 37,439,023 | 33,933,166 | +3,505,857 | 5.88 |
| 2025-12-31 | 33,933,166 | 28,827,852 | +5,105,314 | 6.92 |
| 2025-12-15 | 28,827,852 | 28,728,824 | +99,028 | 5.44 |
| 2025-11-28 | 28,728,824 | 24,958,080 | +3,770,744 | 3.66 |
| 2025-11-14 | 24,958,080 | 25,922,850 | -964,770 | 3.56 |
| 2025-10-31 | 25,922,850 | 24,416,434 | +1,506,416 | 5.31 |
| 2025-10-15 | 24,416,434 | 27,694,381 | -3,277,947 | 2.37 |
| 2025-09-30 | 27,694,381 | 24,801,814 | +2,892,567 | 4.18 |
| 2025-09-15 | 24,801,814 | 22,348,965 | +2,452,849 | 3.34 |
| 2025-08-29 | 22,348,965 | 22,636,104 | -287,139 | 4.81 |
| 2025-08-15 | 22,636,104 | 23,127,867 | -491,763 | 3.89 |
Showing 1–22 of 22 settlements
Key facts
CIK
1434868
CUSIP
29664W105
13F (30d)
182 filings
179 filers
Visit website
Investor relations